Pricing

Similar Allegations In Xarelto Lawsuit Cases Lead To Consolidation By JPML

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

TheProductLawyers.com reports on the numbers of Xarelto lawsuits that have been consolidated together because of the uniformity of the allegations being made about the drug's dangerous side effects. All plaintiffs are claiming that Xarelto may place patients using the drug at a much higher risk for dangerous and life-threatening instances of uncontrollable bleeding, as well as other adverse impacts. The consolidated cases also share the same defendants, Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer AG.

There are currently two groups of consolidated cases. The first is a mass tort program in Philadelphia, PA that was completed under the direction of the Court of Common Pleas. There are 550 cases in this tort program and there may be a possibility of more lawsuits being filed.

The second group of cases number over 2,800 and were consolidated into a Multidistrict Litigation (MDL) with a decree made by the U.S. Judicial Panel for Multidistrict Litigation (JPML) and has been assigned number 2592. The cases are being overseen and administered in a federal court in the Eastern District of Louisiana. Plaintiffs in all of the cases in the multidistrict litigation (MDL) concur that the manufacturers of Xarelto were negligent and reckless in releasing Xarelto onto the market without fully disclosing the nature of the potentially dangerous risks associated with the drug.

Xarelto has also been the recipient of two black box warnings by the U.S. Food and Drug Administration (FDA). A black box warning is the most severe warning that can be issued by the FDA and can frequently be a precursor to a drug being pulled from the market.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

About TheProductLawyers.com :

TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.

Contact TheProductLawyers.com:

Banville Law

165 West End Ave #1h,
New York, NY 10023

888-478-9711

Additional News Releases From TheProductLawyers.com:

November 30, 2016Research Indicates New Form Of Treating Ovarian Cancer As Talcum Powder Lawsuit Numbers Climb

November 30, 2016Parties in Talcum Powder Lawsuit In Missouri Exchange Briefings

November 30, 2016J&J Requests Disclosure Of Third Party Litigation Financing In Talcum Powder Lawsuit

November 30, 2016Delaware Sees 10 New Talcum Powder Lawsuit Filings

November 29, 2016Philadelphia Talcum Powder Lawsuit Filed Against Johnson & Johnson To Proceed

November 29, 2016Pennsboro Woman Files Talcum Powder Lawsuit On Behalf Of Her Deceased Mother

November 29, 2016Bioimaging Helps Early Detection Of Ovarian Cancer As Talcum Powder Lawsuit Filings Continue

November 28, 2016FDA Follow-Up: How Officials Have Responded To The Influx Of Talcum Powder Lawsuit Filings

November 28, 2016Talc Uses: A Look At The Product At The Center Of Talcum Powder Lawsuit Filings

November 28, 2016More Women Encouraged To File A Talcum Powder Lawsuit After Verdicts